Transcatheter thrombolytic therapy for symptomatic thrombo-occlusion of inferior vena cava filter

  • Authors:
    • Liang Xiao
    • Jing Shen
    • Jia-Jie Tong
    • Zhe Zhang
    • Xiao-Lin Mu
    • Zheng-Jia Yi
    • Shuo Bai
    • Ke Xu
  • View Affiliations

  • Published online on: November 30, 2012     https://doi.org/10.3892/etm.2012.843
  • Pages: 533-538
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Thrombus within an inferior vena cava (IVC) filter reduces filter patency and venous return from the lower extremities, and may progress to complete IVC occlusion. The clinical experiences and outcomes of transcatheter thrombolytic therapy for symptomatic IVC thrombosis following filter implantation have not been widely reported. The aim of the current study was to evaluate the efficiency and safety of transcatheter thrombolysis for the treatment of symptomatic IVC thrombosis in patients with implanted IVC filters. Transcatheter thrombolysis was used to treat 5 patients with thrombosis of the filter-bearing IVC causing symptoms in 10 limbs from October 2005 to September 2010. The patients were implanted with a second IVC filter through the right internal jugular vein, followed by recanalization of the occluded IVC and intravenous transcatheter thrombolysis. The IVC filters were retrieved through the femoral or right internal jugular vein after the thrombus had dissolved. Technical and clinical outcome, complications and postoperative pulmonary embolism were monitored. A total of 5 filters were implanted and 6 filters were retrieved later. Technically and clinically successful recanalization and thrombolysis were achieved in 5 of 5 patients and 10 of 10 symptomatic limbs. The median thrombolysis period was 13 days (range, 8-14 days). The median dwell time for the filters that were removed was 50.5 days (range, 14-73 days). No major bleeding occurred during the current study. During clinical follow-up, no clinically detectable pulmonary embolism was observed. Endovascular recanalization and transcatheter thrombolysis of IVC thrombosis are efficient, feasible and safe in the presence of an IVC filter.
View Figures
View References

Related Articles

Journal Cover

February 2013
Volume 5 Issue 2

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Xiao L, Shen J, Tong J, Zhang Z, Mu X, Yi Z, Bai S and Xu K: Transcatheter thrombolytic therapy for symptomatic thrombo-occlusion of inferior vena cava filter. Exp Ther Med 5: 533-538, 2013
APA
Xiao, L., Shen, J., Tong, J., Zhang, Z., Mu, X., Yi, Z. ... Xu, K. (2013). Transcatheter thrombolytic therapy for symptomatic thrombo-occlusion of inferior vena cava filter. Experimental and Therapeutic Medicine, 5, 533-538. https://doi.org/10.3892/etm.2012.843
MLA
Xiao, L., Shen, J., Tong, J., Zhang, Z., Mu, X., Yi, Z., Bai, S., Xu, K."Transcatheter thrombolytic therapy for symptomatic thrombo-occlusion of inferior vena cava filter". Experimental and Therapeutic Medicine 5.2 (2013): 533-538.
Chicago
Xiao, L., Shen, J., Tong, J., Zhang, Z., Mu, X., Yi, Z., Bai, S., Xu, K."Transcatheter thrombolytic therapy for symptomatic thrombo-occlusion of inferior vena cava filter". Experimental and Therapeutic Medicine 5, no. 2 (2013): 533-538. https://doi.org/10.3892/etm.2012.843